Unlike existing treatments that require patients to purchase multiple single-dose pens as they titrate their dosage, Zydus plans to introduce an innovative, adjustable single-pen device, allowing patients to seamlessly select and administer varying dose strengths from a single unit, significantly enhancing patient adherence
doi:10.1016/j.diabres.2023.110669
It is not intended for human or veterinary use, diagnosis, or therapeutic application
Those human studies were small and short, so the safety picture is encouraging rather than definitive, and its a conversation worth having with a clinician who can weigh it against your own history
Possible side effects of the Wegovy weight loss pen include: Nausea, vomiting, constipation, or diarrhea during the initial phase these usually improve as the body adapts Risk of low blood sugar
These positive effects on weight loss together with the experimental evidence suggesting that liraglutide exerts its effects directly in the CNS raise the question of whether GLP-1RAs of higher molecular weights, such as dulaglutide and albiglutide, would be as effective as liraglutide in promoting weight loss [23]
